Benitec Biopharma Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Benitec Biopharma Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q3 2019 to Q3 2024.
  • Benitec Biopharma Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending September 30, 2024 was -$4.59M, a 0.2% decline year-over-year.
  • Benitec Biopharma Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$19.4M, a 7.72% decline from 2023.
  • Benitec Biopharma Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$18M, a 13.3% decline from 2022.
  • Benitec Biopharma Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$15.9M, a 23.9% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$4.59M -$9K -0.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q3 2023 -$4.58M -$532K -13.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q3 2022 -$4.05M +$233K +5.45% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q3 2021 -$4.28M -$1.92M -81.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q3 2020 -$2.36M -$1.82M -333% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q3 2019 -$545K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.